DekaBank Deutsche Girozentrale - CHEMOCENTRYX INC ownership

CHEMOCENTRYX INC's ticker is CCXI and the CUSIP is 16383L106. A total of 73 filers reported holding CHEMOCENTRYX INC in Q4 2015. The put-call ratio across all filers is 1.56 and the average weighting 0.1%.

Quarter-by-quarter ownership
DekaBank Deutsche Girozentrale ownership history of CHEMOCENTRYX INC
ValueSharesWeighting
Q3 2022$1,554,000
+104.5%
30,7000.0%0.01%
+150.0%
Q2 2022$760,000
-1.0%
30,7000.0%0.00%0.0%
Q1 2022$768,000
-22.8%
30,700
+10.0%
0.00%0.0%
Q4 2021$995,000
+92.1%
27,900
+3.0%
0.00%
+100.0%
Q3 2021$518,000
+38.5%
27,1000.0%0.00%0.0%
Q2 2021$374,000
-71.9%
27,1000.0%0.00%
-75.0%
Q1 2021$1,331,000
-18.8%
27,1000.0%0.00%
-33.3%
Q4 2020$1,640,000
+88.9%
27,100
+64.2%
0.01%
+50.0%
Q3 2020$868,000
+703.7%
16,5000.0%0.00%
+300.0%
Q3 2019$108,000
-63.4%
16,500
-50.0%
0.00%0.0%
Q2 2019$295,000
+13.9%
33,000
+65.0%
0.00%
-50.0%
Q1 2019$259,000
+49.7%
20,000
+21.2%
0.00%
+100.0%
Q4 2018$173,000
-33.2%
16,500
-17.5%
0.00%
-50.0%
Q3 2018$259,000
-7.5%
20,0000.0%0.00%0.0%
Q2 2018$280,0000.0%20,0000.0%0.00%0.0%
Q1 2018$280,000
+382.8%
20,000
-20.0%
0.00%
+100.0%
Q1 2016$58,000
-68.1%
25,000
+11.1%
0.00%
-50.0%
Q4 2015$182,000
+36.8%
22,500
+2.3%
0.00%0.0%
Q3 2015$133,000
-23.1%
22,000
+4.8%
0.00%0.0%
Q2 2015$173,000
+11.6%
21,000
+2.4%
0.00%0.0%
Q1 2015$155,000
+2.0%
20,500
-10.9%
0.00%0.0%
Q4 2014$152,000
+32.2%
23,000
-9.8%
0.00%0.0%
Q3 2014$115,000
-21.2%
25,500
+2.0%
0.00%0.0%
Q2 2014$146,000
-17.0%
25,000
-5.7%
0.00%
-33.3%
Q1 2014$176,00026,5000.00%
Other shareholders
CHEMOCENTRYX INC shareholders Q4 2015
NameSharesValueWeighting ↓
Tri Locum Partners LP 436,300$15,886,0006.25%
TANG CAPITAL MANAGEMENT LLC 500,000$18,205,0003.66%
Integral Health Asset Management, LLC 200,000$7,282,0002.02%
Sofinnova Investments, Inc. 731,222$26,624,0001.56%
Lisanti Capital Growth, LLC 231,035$8,412,0001.22%
Darwin Global Management, Ltd. 161,802$5,891,0000.90%
Cormorant Asset Management, LP 400,000$14,564,0000.87%
Perceptive Advisors 2,830,892$103,072,0000.80%
Avidity Partners Management LP 644,400$23,463,0000.50%
Eventide Asset Management 1,040,000$37,866,0000.48%
View complete list of CHEMOCENTRYX INC shareholders